The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective WSG phase III PlanB trial: Final analysis of adjuvant 4xEC→4x doc vs. 6x docetaxel/cyclophosphamide in patients with high clinical risk and intermediate-to-high genomic risk HER2-negative, early breast cancer.
 
Nadia Harbeck
Honoraria - Amgen; Celgene; Genomic Health; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Celgene; Hexal; Novartis; Pfizer; Roche/Genentech; Sandoz
Research Funding - Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Oleg Gluz
Honoraria - Genomic Health; NanoString Technologies; Roche
Travel, Accommodations, Expenses - Celgene; Teva
 
Michael R. Clemens
No Relationships to Disclose
 
Wolfram Malter
No Relationships to Disclose
 
Toralf Reimer
No Relationships to Disclose
 
Benno Nuding
No Relationships to Disclose
 
Bahriye Aktas
No Relationships to Disclose
 
Andrea Stefek
No Relationships to Disclose
 
Anke Pollmanns
No Relationships to Disclose
 
Fatemeh Lorenz-Salehi
No Relationships to Disclose
 
Christoph Uleer
No Relationships to Disclose
 
Petra Krabisch
No Relationships to Disclose
 
Sherko Kummel
Honoraria - Roche
Consulting or Advisory Role - Amgen; Celgene; Genomic Health; Novartis; Roche
 
Cornelia Liedtke
Honoraria - Amgen; AstraZeneca; Celgene; Eisai; Gedeon Richter; Genomic Health; GlaxoSmithKline; Novartis; Pierre Fabre; Roche; Teva
Consulting or Advisory Role - Genomic Health; Novartis; Pierre Fabre; Roche; Teva
Speakers' Bureau - Genomic Health
Research Funding - Boehringer Ingelheim; Eisai; Novartis; Roche
Travel, Accommodations, Expenses - Celgene; PharmaMar; Roche; Teva
 
Steven Shak
Employment - Genomic Health
 
Rachel Wuerstlein
Honoraria - Genomic Health; NanoString Technologies; Novartis; Pfizer; Roche
 
Matthias Christgen
No Relationships to Disclose
 
Ronald Kates
No Relationships to Disclose
 
Hans Heinrich Kreipe
Honoraria - AstraZeneca; Genomic Health; Roche
 
Ulrike Nitz
Honoraria - Genomic Health; Roche